Guidelines on perioperative optimization protocol for the adult patient 2023.
Sébastien Bloc, Pascal Alfonsi, Anissa Belbachir...
https://pubmed.ncbi.nlm.nih.gov/37295649/Actively Recruiting
Led by Institut Mutualiste Montsouris · Updated on 2025-09-25
310
Participants Needed
1
Research Sites
14 weeks
Total Duration
Hip replacement surgery is a common procedure in France, with about 150,000 surgeries performed annually. While recovery has improved, some patients experience severe pain after surgery that requires high doses of morphine, which can cause side effects and delay healing. This trial evaluates whether using a nerve block called the Supra-Inguinal Fascia Iliaca Block SIFIB as a rescue pain relief after hip replacement can help reduce pain and improve walking ability. The study focuses on patients who have significant pain after surgery, rather than giving the nerve block to all patients. Participants receive standard general anesthesia for their hip replacement surgery. After surgery, patients who report significant pain are randomly assigned to receive either the SIFIB nerve block with a local anesthetic called ropivacaine or a placebo injection of saline, both guided by ultrasound. The nerve block involves injecting 40 ml of 0.1% ropivacaine near the nerves around the hip to numb the area. The placebo group receives 5 ml of saline under ultrasound guidance. Pain relief and recovery are compared between these groups. During the study, participants will be monitored for pain levels at various times after surgery 2, 6, 12, and 24 hours, morphine use, length of hospital stay, and patient satisfaction. The primary outcome is a composite measure of pain relief two hours after surgery. The study also tracks the ability to walk and any side effects. Participation involves follow-up assessments for up to a week after surgery to carefully observe recovery and pain control.
CONDITIONS
Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty
C
Chahrazad Bey Boumezrag
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institut Mutualiste Montsouris
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 24 hours post-operatively
Participants receive total hip arthroplasty under general anesthesia followed by randomization to receive either an ultrasound guided supra inguinal fascia iliaca block or a placebo injection as rescue analgesia if they experience significant pain post-operatively.
1 post-anesthesia care unit visit (in-person)
Duration - Up to 1 week
Participants are monitored for morphine consumption, pain levels, patient satisfaction, and length of hospital stay following the intervention.
Multiple visits during hospital stay (approximately 2 to 3 days, up to 1 week)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sébastien Bloc, Pascal Alfonsi, Anissa Belbachir...
https://pubmed.ncbi.nlm.nih.gov/37295649/Chen Changjun, Zhao Xin, Luo Yue...
https://pubmed.ncbi.nlm.nih.gov/36597677/Xiao-Yan Zhang, Jian-Bao Ma
https://pubmed.ncbi.nlm.nih.gov/30683117/Hans J Gerbershagen, Sanjay Aduckathil, Albert J M van Wijck...
https://pubmed.ncbi.nlm.nih.gov/23392233/M Anger, T Valovska, H Beloeil...
https://pubmed.ncbi.nlm.nih.gov/34015859/Stavros G Memtsoudis, Crispiana Cozowicz, Janis Bekeris...
https://pubmed.ncbi.nlm.nih.gov/34433647/Matthias Desmet, Kris Vermeylen, Imré Van Herreweghe...
https://pubmed.ncbi.nlm.nih.gov/28059869/Institut Mutualiste Montsouris
Lead Sponsor